Healthcare Contract Research Organization Market Analysis Report By Type, By Service, By Region And Segment Forecasts From 2021 To 2028

Report ID: MN17617124  |  Published: September 2021  |  No of Pages: 120
Format: Electronic (PDF)  |  Industry: Healthcare IT


The global healthcare contract research organization market was prized by USD 39.6 billion in 2020. It is estimated to witness 6.6% CAGR from 2021 to 2028.


The ending of the patent in healthcare division, rising funds for R&D plans, and inclination for sub contracting the actions because of price and time restriction, are the important factors expected to propel the market for healthcare CRO, during the near future.


The partnerships for contract research provide advanced services and hence government institutes have a preference for transferring projects to Contract Research Organizations (CROs), in this manner helping the expansion of the market.

Effect of Covid-19

Similar to other sectors the market for healthcare CRO has obviously got influenced, due to the global eruption of Covid-19 pandemic, clinical trials are suspended because the enrollment of the patients has happened to be strained and working places are closed.

The research for the Covid-19 treatments has increasing by a considerable pace. The global research group has begun spotting the medicinal treatment for Covid-19, by way of monitoring together the presented as well as fresh medicines, for their capability to lessen the indications and stop the duplication of the virus.

Type Insight

The clinical section held the major, 76.7% revenue share and led the healthcare contract research organization market, in 2020, on the basis of type. The share is credited to the demand for higher technologies, increasing number of biologics and the necessity for custom-made medication, along with orphan drugs. The issues like demand for contract research organizations to carry out clinical test, technical progression and globalization of clinical examinations, are additionally expected to propel the enlargement.

Owing to the reality that they are one of the major costly steps of a clinical trial, subcontracting of phase III clinical trials to healthcare contract research organizations produced the maximum revenue in 2020. Roughly 90.0% of the operating costs take place, at some stage in the clinical improvement of a medicine stems, from this phase.

The preclinical studies section is expected to observe the fast enlargement percentage of 8.3%, throughout the forecast period. Growth in the figure of preclinical tests concerning big molecules plus the rising necessity to limit the R&D expenditure is likely to add to the increasing demand for superior preclinical contract research organization, in this manner adding to the expansion of the market.

Service Insight

The clinical monitoring section held above 18.0% revenue share and dominated the healthcare CRO market, in 2020. Furthermore, it is expected to retain its place, during the forecast period. This may be credited to the rising figure of clinical trials as well as the necessity to check those revisions, which are generating additional demand for the services.


During the previous decade clinical research is being subcontracted to contract research organizations because of diverse causes, for example, technological proficiency along with the price efficiency. The initiation of instantaneous information attainment procedures and smart analytics are projected to enhance the monitoring of clinical information, within the healthcare division. Attainment of concurrent information linked with the toxicity and safety of the medicine facilitate before time recognition of test inaccuracy along with it makes possible appropriate rectifications like execution or revamping of the test, in this manner boosting the expansion of the section.

The regulatory/medical affairs division is expected to observe the highest, 11.1% enlargement speed during the forecast period. The sub-contracting for regulatory affairs is speedily increasing because of the medicines in pipeline, function of clinical trial, rise in R&D actions and listing of the product. The rising demand for doing more with less, to get endorsement for fresh products and preserve compliance is expected to maintain the expansion of the market.

Regional Insight

In 2020, Asia Pacific held major, 42.0% revenue share and led global healthcare contract research organization market. Furthermore, the state is projected to develop by a fast speed during the forecast period. This may be credited to the system of rules according to the expected standards, accessibility of assorted populations, greater occurrences of chronic circumstances, and effortless enrollment of the patients as well as withholding.

Moreover, positive support by the government is, furthermore, adding to the expansion of the market. Such as, the Central Drugs Standard Control Organization (CDSCO) prepared fresh regulations that are expected to decrease the necessary period for sanction to almost 30-60 days, as a result, pushing the expansion of the market.

As a result of the maximum number of trials carried out as well as sub contracted within the region, North America held the major share of the market, in 2020. Besides, increasing encouragements for R&D actions by the government by means of finances and donations to research organizations as well as the companies has pushed this local market.


The healthcare contract research organizations are involved in joining forces to endorse their services on worldwide stage, along with presenting better services. To maintain the functioning of clinical trials during in the present pandemic situation, the market contestants are implementing the diverse models particularly virtual experimental testing. For example, PRA Health Sciences is presently carrying out, globally, more than 40 hybrid and virtual tests for their customers. It is toting up more than a million patients in above 30 nations.

Some of the companies for healthcare contract research organization market are:

    • PRA Health Sciences
    • Wuxi AppTec
    • Pharmaron
    • Medidata Solutions, Inc.
    • Charles River Laboratories International, Inc.
    • Pharmaceutical Product Development, LLC
    • IQVIA Holdings Inc.
    • CTI Clinical Trial & Consulting
    • GVK Biosciences Private Limited
    • Syneos Health
    • ICON, plc
    • Parexel International Corporation
    • Covance Inc.

Report Scope

Report Attribute


Market size value in 2021

USD 42.3 billion

Revenue forecast in 2028

USD 66.0 billion

Growth Rate

CAGR of 6.6% from 2021 to 2028

Base year for estimation


Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD Million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Type, service, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Switzerland; Belgium; Netherlands; Austria; India; China; Taiwan; Japan; Korea (republic); Australia; Indonesia; Malaysia; Singapore; Thailand; Brazil; Mexico; Argentina; Colombia; Chile; South Africa; Saudi Arabia; UAE; Iran; Israel; Egypt

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Key companies profiled

IQVIA HOLDINGS INC.; Covance Inc.; Pharmaceutical Product Development, LLC; PAREXEL INTERNATIONAL CORPORATION; CHARLES RIVER LABORATORIES INTERNATIONAL, INC.; ICON, plc; Medidata Solutions, Inc.; Syneos Health; Pharmaron; GVK Biosciences Private Limited; Wuxi AppTec; MEDPACE HOLDINGS, INC.; PRA Health Sciences; CTI Clinical Trial & Consulting

customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Million Insights has segmented the global healthcare contract research organization market report on the basis of type, service, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)
    • Drug Discovery
        • Target Validation
        • Lead Identification
        • Lead Optimization
    • Pre-clinical
    • Clinical
        • Phase I Trial Services
        • Phase II Trial Services
        • Phase III Trial Services
        • Phase IV Trial Services

• Service Outlook (Revenue, USD Million, 2016 - 2028)
    • Project Management/Clinical Supply Management
    • Data Management
    • Regulatory/Medical Affairs
    • Medical Writing
    • Clinical Monitoring
    • Quality Management/ Assurance
    • Bio-statistics
    • Investigator Payments
    • Laboratory
    • Patient and site Recruitment
    • Technology
    • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Switzerland
        • Belgium
        • Netherlands
        • Austria
    • Asia Pacific
        • India
        • China
        • Taiwan
        • Japan
        • Korea (Republic)
        • Australia
        • Indonesia
        • Malaysia
        • Singapore
        • Thailand
    • Latin America
        • Brazil
        • Mexico
        • Argentina
        • Colombia
        • Chile
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE
        • Iran
        • Israel
        • Egypt

What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
Connect With Expert
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service

Get a Free Sample

FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...